News
New malaria drug requires just one dose and appears twice as effective as existing regimen
Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective as the best current medicine...
Industry Reports
Hybrigenics 2012 first-half results
Plus 5 per cent growth of Hybrigenics’ operating revenues An exceptional revenue of EUR 0.96 million EUR 3.3 million...
Drug Research
FDA approves ThromboGenics vitreomacular adhesion therapy
The USFDA has approved ThromboGenics' Jetrea (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion (VMA). The approval was based...
Production & Manufacturing
Mylan Labs to buy SMS Indian manufacturing unit
Mylan Laboratories has agreed to purchase SMS Pharmaceuticals' manufacturing unit-VI in Visakhapatnam, Andhra Pradesh, India, for a total sum of INR1.73bn ($33m). ...
Clinical Trials
Novavax pandemic influenza vaccine meets endpoints in two Phase 1 trials
Novavax A/H5N1 avian influenza vaccine candidate has met safety and immunogenicity endpoints in two Phase 1 clinical trials. The...
Industry Reports
Johnson & Johnson Reports 2012 Third-Quarter Results
Sales of $17.1 Billion increased 6.5% Versus 2011 Third Quarter; Third-Quarter EPS was $1.05 Excluding Special Items, 2012 Third-Quarter...
Press Releases
FDA Advisory Committee Unanimously Recommends Approval of Gattex® (teduglutide) for Adults with Short Bowel Syndrome (SBS)
NPS Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today that the U.S. Food and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read